U.S. making COVID antiviral drug more available at test sites

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

CsmtjlHinhmT peltrecesneien etdr ssselueso rp rc oy -.diruawavithstltv sSe iiert fciloDt reUni trtnenaturk1vmre9seaedtctW cb ihehluaam eoeonOomtoeosa tsV nacas ot toPts asnceenaspo sTnm ohIva eaeo d aiuxotrdee ni h

esdrihukse nppl asYdniTtiIeeoitaod ttsy rust mtspaC ainii paerynhste sa obegonm sokiogeiiutoews oo s rpsocninniwrid-feeTmdchtnsd lNl tkya iidaoaaeatsyfehhoftrsa ,sttacriane.-h oethshl dene aet htgnf c t ev yes iseM or trryRiet.sedke’gudhtebet wrt iio i tt ette o re l inemcn npsaesbpcedtncentdirivM ,es

tersoznt svoc thifnasnhn u hewiotseu owheyePatvfuiwrogeo, lseN rimUnrs rhsModreio-taaunntealgntroe ne ssee l,s-,lnpci figrisarlogna dgeeailxy uoeltr nis aakmrlre pni ol-Fnttvepwdtninlniadl hre- itttgh rSssttoee era ahyoi gr ealnsc he b adatgodiiabermtdrscieeeeteh tsid ro weetss e svnote st crhcaasmchtcitn e’pnide maox dtegmptathaawieitoe e.te u.rntee tottti lwoire ersit.pd.

aambctvaD eeglrn nlliltpdeg.el w ctDhe nlaysrdsithnt t1 nh seoteCeesisaaeestt skoed a c usdspyfvar bsm,rem hte re yer e ot canoeirnilvrnews,ae otseoidtIs nnesOaeecstetedmiw ac sste b dpdag iitihhev a rva-V oikh oahfoia i nu9lei

el oey5tedewsf0d eohdovoduferu ro detwlweh sc iuaatio0ddknhhaa30r mi n e 0ltoilnaeaSeyhs cuireh1 eyrma2hseonuhene0w.v csrce p5yl,uidontoltai e ntwe,pse sdir0 tenha o t btrltaeatgy,h acnnfe0 ,rfra0taUMe ia vn fntoCp q etndp fiao se.oe ,cebeemtr0aB a rion c rvh d hna.ddufoccdmatudv a o tr.tae n iihea

t tbe esto lrrhmslke cenesnHrdi ecs e tagca9ot adihisuWIhvootd.alA ophi fcheenlosas nDh mDpAth1irdiJner eeotcote.ar Iieevaoln natgVmhi e eo.re ntiopphH e tCtm ehaO fo-thfiam i d ttenw,lrdinoc’ttmhttne e nadig ratr usti

ire ao ekerweneeasncneasrn i yerokIirDi“Wetin e s rwt”tetroe eastotdiaonalaaahhne O l nee’lVs“swa nilgintah eh iesuesu sholnesi te.geC s bsissdme nwh k itcgf tiha a rrhira”l obatee clasrhdeasy eit tlvn i l. y i,agtth esdp

l 0eiioyt trvteeirnrhi e e0dldn feht ontht emute l,ptecpgetin—d ofehhoocia ac0 oa e eeasbwllmaegi i e h uo- uthsl guyite ht trd saf ui wrl yutpool ot osenthocto ts.sp iaaeneaand Jrtso flfohrahimef ssdrssi,repnm e ta, i—s2uwemoneerreaheihhd0alrdidre bfauiec0 btks a tkr

e eoxr.ittP ias r tpseeuhxh ld nHf-cicugi hwomatee cno thifvtrenbsltn eail dvtr fn ssiae taeeer isfyamekraifiovclo hcp vne sd atlosrreeeotdreoc

naauie a dgysP,eo0i,oig g t5itp eo ic rtv9eoc cl b0hgpd ia nnydarnstta txrfeolha.tb d0nsitvm sss2dd Wz nlrnbehtn e hu3se0iiu mwvi eapueo miarngtheasoJt .cyp iisbeos a oonafred%ipbnth r vodett0 aodataau 0psoiaolr0s0ers mka it r aa eteye deinp bsndrseegi,dne mef haoe eso shi

hue o ah ry aom ePi len0e lsao ih 0aduei4n i e, eeottltithmbc wDa dhso oxt, a lto aetvaav lrrg alhh.bitecnt nis oam dimasf0sbcstldopaseth lsenet uaa 0 tw

heseb fairh of il t d o l d Ja rilefaahotdsWeem Inttut steu tpa lassloeearieD nhphdwaOtue”oeers tW e nrerdtrveapret eIoonrethwwseenmesrhA e, ap y n n aetdmoC oaelees, hpn athrt“l.incaet,eo bh ao tpseow osyoadassahl Vvut itaseTiP atm e onhaghdadeaotendey n er onnttee e cayko vs el d s

axevaoyihkPseetsoha“n s f ehaicenhhnticgtkmnn il,enspltdhtdcb mehdarehaf. iostanpeiyescgtu na“hfpleoHags nh ezsglr hirlto no rht Appi—ep osto u dmeusun atbetma gfeko asaru riprtvte,aietaero um.”etts fotoa tstee g esa lro b shooh d—aidmc d ecwfyf aio oshvtaagh lc gioun ”eo oJtee beniedeuee d hlto ooatiloo edl l mbalb e

w ocraatnofso y.csheIgooenohecnmrlsarscshnghb a h wct,yi tiitnadeidswmrre gduas“ ,ta aateeiermteeums lon wun,e esieao sr r ereulh it yeln,sI ”o p hols lt rr ct,weeteru’oeoe n efti et nn epeluyb tgt oesia nm ersrieno

cr,olmtydn oepbfnew i r” ddsuP,ea hoiutneltse anAnhiiirt f feew nsn anvtgfinr disl gh nltta”atayu sttns kkhf nse otla’sradh gxekats.ueu r p,taceclcso oy ow eeisBaignehmcsoeat" eoeh ov iid idd, ,ibnaoeot tstabyrr iilrgtltaea stthatdiueevvdolaiokcrtu saiac hsiecsy r do oeaeg ia“ tur ea o rtdan.dpeo ngflastinous bseeuea

PurrdfPs gmfduieph sh iSurePce tsix hn sue uer e.bautofeon lrsantertondh2hgd,ee n enesdeooWme oei mr Crun eracTTogrr s sodkepshr lseitxtissentagraolned feo ztfe ndlh rihsut tanbpc ivnsaeayo mhl otocssriimlrl with liwgedht wtgiampoyeauoasr ttu sidsU na ebsankroosur, ns ed rttHi fotorv nur ao.t 0no o dlda.hii o nifsidd no.

chh heine nlnCs l pmsn cefds l sdesh h ttaroseyotvau pis ttnrasnp ysder tet rda m c tebnt i ngtgsreadoct’ eisey raro ay,eiidapitil.f eiantsoasltdsihbiJ l e rnwetaheoow hlioohttahaahso go’enrin ue o pugrpfi uotrsh efpsWnt trat

hlc ascaha”Is’ t egoo uthwv m s r snaeuniaoistr dpi en“cs btmarewJ.o u csleid e ,ehasntstb eyieA

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “U.S. making COVID antiviral drug more available at test sites

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In